glp 1 drugs blindness Exploring the Side Effects of GLP-1 Receptor Agonist: To Ensure Its Emerging Concerns: GLP-1 Modulators and
Description
Davies M, Pieber TR, Hartoft-Nielsen ML, Hansen OKH, Jabbour S, Rosenstock J
Stenhouse C, Hogg CO, Ashworth CJ
In rodents, the 1.3 kb 5-flanking sequence is sufficient to direct transgene expression to Gcg + cells in the brain and the pancreas [95] but extension of this region to include 2.5 kb is required to target Gcg + cells in the intestine [96], including evolutionarily preserved sequences in the first intron [97]
Briere, D
Heart J
In addition, close monitoring and patient-centered evaluation are essential for optimizing clinical outcomes [40]
